The Osteopontin Market is evolving rapidly due to the protein’s expanding role in disease diagnostics and therapeutic research. Heightened focus on early disease detection, particularly in oncology and cardiovascular disorders, is stimulating demand for osteopontin-based assays and analytical tools. Market growth is further supported by technological advancements in molecular biology, increasing clinical research activities, and broader adoption of precision medicine approaches worldwide. Read more - https://www.theinsightpartners.com/reports/osteopontin-market

Branded Generics Market Trends: Growth Strategies, Regional Insights & Key Developments The Branded Generics Market is gaining prominence in the global pharmaceutical landscape, driven by lower-cost drug alternatives, expanded access to healthcare, and a growing burden of chronic illnesses. Branded generics are therapeutically equivalent to their original branded counterparts but carry a proprietary name post-patent. By providing equivalent treatment at a more accessible price point, they offer significant value to patients, clinicians, and insurance providers. The branded generics market size is projected to reach US$ 570.40 billion by 2031 from US$ 258.85 billion in 2023. The market is expected to register a CAGR of 10.38% during 2023–2031. The rising utilization of branded generics by healthcare providers and professionals is likely to remain a key trend in the market. Read More - https://www.theinsightpartners.com/reports/branded-generics-market